Meseclazone
 | |
| Systematic (IUPAC) name | |
|---|---|
|
7-chloro-2-methyl-3,3a-dihydro-2H,9H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 29053-27-8 |
| ATC code | none |
| PubChem | CID 34445 |
| ChemSpider | 31698 |
| UNII |
51KFT71THG  |
| KEGG | D04941 |
| ChEMBL | CHEMBL2104738 |
| Chemical data | |
| Formula | C11H10ClNO3 |
| Molar mass | 239.66 g/mol |
| |
Meseclazone (W-2395), also known as 2-methylseclazone, is a non-steroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]
See also
References
- ↑ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- 1 2 3 Rainsford, K. D. (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.